Improving Preterm Outcomes by Safeguarding Maternal Mental Health
Visão geral do estudo
Status
Condições
Intervenção / Tratamento
Descrição detalhada
Preterm infants are born at biological risk for poor health and developmental outcomes; and those born to low-income families face additional social risks known to further interfere with healthy child development. In its 2006 report, Preterm Birth, the Institute of Medicine (IOM) stated the public health importance of optimizing the developmental outcomes of preterm infants, and specifically called for novel postnatal intervention strategies to accomplish this goal. Our proposed strategy is based on the premise that preventing maternal depression - and optimizing maternal functioning in specific domains that mediate the relationship between maternal depression and adverse child effects - will ultimately improve the developmental outcomes of this vulnerable child population.
Problem Solving Education (PSE) is a cognitive behavioral strategy that aims to impart recipients with skills to reduce the impact of stress on personal functioning, and thereby prevent depression. The present project is a randomized trial of a 6-session intervention based on PSE. the investigators aim to enroll 325 mother-infant dyads in four NICUs - Boston Medical Center, Tufts Medical Center, Beth Israel Deaconess Medical Center, and Brigham and Womens Hospital. Over 12-months of follow-up, the investigators will assess the effects of PSE on a series of outcome measures for mothers, a series of measures that represent risk mechanisms by which maternal depression is theorized to impact young children, and a series of child functioning measures.
Primary aims. Regarding outcomes for mothers, the investigators aim to:
- Decrease the incidence of major depressive episode (MDE) and improve depressive symptom trajectories during the first postpartum year; and
- Improve general and parental functioning, as measured by valid and reliable scales.
Secondary aims. Regarding risk mechanisms and child outcomes, the investigators aim to:
- Improve mothers' sense of mastery, and decrease their caregiver burden and social isolation;
- Improve adherence to evidence-based quality indicators for NICU follow-up care;
- Improve maternal sensitivity and mother-child interaction patterns; and
- Improve infant social engagement, emotionality, and cognitive functioning.
Exploratory aims. the investigators will explore the role of a brief set of potential intervention moderators:
- On the infant level: severity of infant illness.
- On the maternal and family level: maternal trauma history, extended family functioning, and intervention adherence.
Tipo de estudo
Inscrição (Real)
Estágio
- Não aplicável
Contactos e Locais
Locais de estudo
-
-
Massachusetts
-
Boston, Massachusetts, Estados Unidos, 02215
- Beth Israel Deaconess Medical Center
-
Boston, Massachusetts, Estados Unidos, 02115
- Brigham and Women's Hospital
-
Boston, Massachusetts, Estados Unidos, 02111
- Tufts Medical Center
-
Boston, Massachusetts, Estados Unidos, 02118
- Boston Medical Center
-
-
Critérios de participação
Critérios de elegibilidade
Idades elegíveis para estudo
Aceita Voluntários Saudáveis
Gêneros Elegíveis para o Estudo
Descrição
Inclusion Criteria:
- Baby is 26-34 weeks gestational age
- Baby qualifies to receive Medicaid
- Mother comfortable in English or Spanish
- Singleton or twin gestation
- Baby is expected to survive
Exclusion Criteria:
- Mother in major depressive episode or endorses suicidality
- Mother with psychosis or otherwise cognitively limited
- Mother with known active substance use; custody of infant uncertain
- Infant is critically ill
- Triplets or higher number gestation
- Mother who is enrolled in another study receiving the same intervention that we are testing
Plano de estudo
Como o estudo é projetado?
Detalhes do projeto
- Finalidade Principal: Prevenção
- Alocação: Randomizado
- Modelo Intervencional: Atribuição Paralela
- Mascaramento: Triplo
Armas e Intervenções
Grupo de Participantes / Braço |
Intervenção / Tratamento |
|---|---|
|
Experimental: Problem Solving Education tailored to NICU
NICU-PSE integrates motivational interviewing and problem solving, with ongoing monitoring and linkage to mental health services for mothers with worsening depressive symptoms over time.
The intervention is provided over six sessions, including three tailored, post-discharge sessions, which address issues common to families of preterm infants: caregiver burden, complexity of medical follow-up, and social reintegration following hospitalization.
|
|
|
Sem intervenção: Control
Both study groups receive standard NICU medical, social work, and nursing services.
At each study site, attending neonatologists and pediatrics residents constitute the medical team, and all families are assigned a social worker.
|
O que o estudo está medindo?
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Incidence of major depressive episode and depressive symptom trajectories
Prazo: one year
|
To measure depression and depressive symptom trajectories, we will combine a dimensional measure (the Quick Inventory of Depressive Symptoms - QIDS) with the diagnostic Structured Clinical Interview for DSM-IV Disorders (SCID).
Administering the QIDS every other month during this time frame will allow us to follow depression symptom trajectories with a repeated measure sensitive to change with treatment.
Administering the SCID at 12-months will allow us to determine timing and severity of major depressive episode(s).
|
one year
|
|
General Functioning
Prazo: one year
|
General functioning will be measured by the mean total SAS-SR score, and mean scores for the family, partner, and social SAS subscales.
The SAS will be administered at 6 and 12 months of follow-up.
|
one year
|
Medidas de resultados secundários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Caregiver burden, mastery and social support
Prazo: one year
|
The Coping Health Inventory for Parents is a valid and reliable instrument designed to measure parents' response to managing family life when they have an ill child.
It will be administered together with the Pearlin Mastery Scale and the Medical Outcomes Survey Social Support Scale.
Administration of these scales will occur at 6 and 12 months of follow-up.
|
one year
|
|
Adherence to recommended NICU follow-up care
Prazo: one year
|
We assess the following measures of adherence to NICU follow-up care:
|
one year
|
|
Parent-child interaction
Prazo: one year
|
We will videotape and microcode a 10-minute mother-infant free play session according to the parent, infant, and dyadic scales of the Coding Interactive Behavior Manual (CIB).
We will assess the following composites: maternal sensitivity; intrusive and withdrawn maternal interactions; and depressed mood and positive affect.
|
one year
|
|
Socio-emotional functioning
Prazo: one year
|
We will assess the CIB infant social engagement composite.
We will assess negative infant emotionality using the 4-minute 'Mask Task' of the Laboratory Temperamental Assessment Battery (Lab-TAB).
|
one year
|
|
Cognitive functioning
Prazo: one year
|
We will use the MacArthur-Bates Communicative Development Inventory.
|
one year
|
Colaboradores e Investigadores
Datas de registro do estudo
Datas Principais do Estudo
Início do estudo
Conclusão Primária (Real)
Conclusão do estudo (Real)
Datas de inscrição no estudo
Enviado pela primeira vez
Enviado pela primeira vez que atendeu aos critérios de CQ
Primeira postagem (Estimativa)
Atualizações de registro de estudo
Última Atualização Postada (Real)
Última atualização enviada que atendeu aos critérios de controle de qualidade
Última verificação
Mais Informações
Termos relacionados a este estudo
Termos MeSH relevantes adicionais
Outros números de identificação do estudo
- H-31407
- R01HD072069 (Concessão/Contrato do NIH dos EUA)
Plano para dados de participantes individuais (IPD)
Planeja compartilhar dados de participantes individuais (IPD)?
Informações sobre medicamentos e dispositivos, documentos de estudo
Estuda um medicamento regulamentado pela FDA dos EUA
Estuda um produto de dispositivo regulamentado pela FDA dos EUA
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .